# Trial of DFP-14927 in Advanced Solid Tumors

Source: https://onco.cc/trials/nct03943004/  
OnCo record `nct03943004` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of DFP-14927 run by Delta-Fly Pharma, Inc., now recruiting.

## Summary

Trial of DFP-14927 in Advanced Solid Tumors is a phase 1 interventional study registered as NCT03943004 by Delta-Fly Pharma, Inc., with 30 participants planned, started 2019-09-30. Conditions recorded: Solid Tumor and Cancer. Interventions recorded: DFP-14927.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03943004
- Phase: 1
- Setting: A Phase I Study of DFP-14927 in Patients With Advanced Solid Tumors
- Sponsor: Delta-Fly Pharma, Inc.
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT03943004: https://clinicaltrials.gov/study/NCT03943004

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [DFP-14927](https://onco.cc/drugs/dfp-14927/)
- companies: [Delta-Fly Pharma](https://onco.cc/companies/delta-fly-pharma/)

---
JSON: https://onco.cc/api/v1/entities/nct03943004.json